| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(78)90495-6 |
| P8608 | Fatcat ID | release_fz6taf7nkfd3vi2ehadyt5eqty |
| P698 | PubMed publication ID | 74675 |
| P2093 | author name string | A R Green | |
| D G Grahame-Smith | |||
| D W Costain | |||
| P2860 | cites work | Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs | Q39080630 |
| Quipazine: Its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour | Q39773302 | ||
| Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor | Q39985530 | ||
| Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA | Q40014537 | ||
| Further observations on the effect of repeated electroconvulsive shock on the behavioural resposes of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine | Q40086791 | ||
| Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine | Q40747144 | ||
| Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan | Q40925721 | ||
| A comparison of techniques in electro-convulsive therapy | Q44671311 | ||
| Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks | Q48280763 | ||
| Long-term effects of electroconvulsive shock therapy on synthesis, turnover and uptake of brain monoamines | Q48363382 | ||
| The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats | Q48510055 | ||
| Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. | Q48876521 | ||
| ECT and the media | Q49406736 | ||
| Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression. The role of the electrical stimulation and of the seizure studied by variation of stimulus intensity and modification by lidocaine of seizure disch | Q52770360 | ||
| EXPERIMENTAL STUDIES OF MEMORY IMPAIRMENT AFTER ELECTROCONVULSIVE THERAPY | Q56454300 | ||
| Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS | Q66843225 | ||
| The Royal College of Psychiatrists' Memorandum on the use of Electroconvulsive Therapy. Part 1-Effectiveness of ECT-a review of the evidence | Q67692131 | ||
| Elevation of brain GABA concentrations with amino-oxyacetic acid; effect on the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats | Q67856788 | ||
| Evaluation of convulsive and subconvulsive shock therapies utilizing a control group | Q73955121 | ||
| Unilateral electro-convulsive therapy | Q74822201 | ||
| Controlled Trial of Straight and Modified Electroplexy | Q78911738 | ||
| P433 | issue | 8058 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 254-257 | |
| P577 | publication date | 1978-02-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Mechanism of the antidepressant action of electroconvulsive therapy | |
| P478 | volume | 1 |
| Q41739738 | 5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice |
| Q37004114 | A study of the incidence of epilepsy following ECT |
| Q41531201 | A theory of convulsive therapy in endogenous depression: Significance of hypothalamic functions |
| Q48164365 | Alterations in GABA metabolism and Met-enkephalin content in rat brain following repeated electroconvulsive shocks |
| Q41638391 | Alterations of Amygdaloid Kindling Phenomenon Following Repeated Electroconvulsive Shocks in Rats |
| Q72427827 | Assessment of peripheral adrenergic activity and its interactions with drugs in man |
| Q42633261 | Brain and serum calcium concentrations following electroconvulsive shock or bicuculline-induced convulsions in rats |
| Q71193915 | Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour |
| Q49125373 | Changes in noradrenergic neuroendocrine responses following repeated seizures and the mechanism of action of ECT. |
| Q40137447 | Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning |
| Q48856290 | Clinical strategies for evaluating ect mechanisms — pharmacological, biochemical and psychophysiological approaches |
| Q40473807 | Convulsive Therapy in Delusional Disorders |
| Q37088815 | Dental management of the patient with major depression |
| Q43745072 | Diazepam administration to mice prevents some of the changes in monoamine-mediated behaviour produced by repeated electroconvulsive shock treatment |
| Q70493663 | Differential effects of flurothyl- and electro-convulsive shock on sexual maturation and prolactin release in the rat |
| Q40155237 | Do antidepressants possess a common mechanism of action? |
| Q48712267 | Dopamine releasing response in rat striatum to single and repeated electroconvulsive shock treatment |
| Q41141018 | Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens |
| Q66705242 | Efficacy of ECT |
| Q59010104 | Electroconvulsive Shock: Effect on Pineal and Hypothalamic Indoles |
| Q52703223 | Electroconvulsive Therapy in Sweden |
| Q48687610 | Electroconvulsive seizures inhibit amygdala kindling: implications for mechanisms of action in affective illness |
| Q72648400 | Electroconvulsive therapy (ECT) increases plasma growth hormone, prolactin, luteinising hormone and follicle-stimulating hormone but not thyrotropin or substance P |
| Q41533213 | Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses. |
| Q42185195 | Electroconvulsive therapy today |
| Q39662597 | Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: Relevance to the mechanism of the antidepressive effect of electroconvulsive therapy |
| Q70808294 | Enhanced growth hormone response to clonidine after repeated electroconvulsive shock in a primate species |
| Q48873368 | Immediate increases in plasma prolactin and neurophysin but not other hormones after electroconvulsive therapy. |
| Q48875772 | Increased permeability of blood brain barrier after electro-convulsive shocks (ECS). |
| Q39641473 | L-tryptophan: a rational anti-depressant and a natural hypnotic? |
| Q39501580 | Neuroendocrine responses as a probe into the mechanisms of action of electroconvulsive therapy. |
| Q52704476 | Nitrous oxide and the bone-marrow. |
| Q28355626 | Ocular myasthenia gravis after D-penicillamine administration |
| Q50179338 | Oestrogen-stimulated neurophysin and outcome after electroconvulsive therapy |
| Q36096163 | On the mechanism of action of electroconvulsive therapy: some behavioural and biochemical consequences of repeated electrically induced seizures in rats [proceedings] |
| Q41641371 | Opiate-like electroencephalographic and behavioral effects of electroconvulsive shock in rats |
| Q44983404 | Physical illness and depression: the effects of acute physical illness on the mental state of psychiatric inpatients |
| Q74337198 | Polyamine oxidase activity in sera of depressed and schizophrenic patients after ECT treatment |
| Q66701115 | Prolactin response to repeated electroconvulsive therapy in acute schizophrenia |
| Q67296295 | Regional GABA concentration and [3H]-diazepam binding in rat brain following repeated electroconvulsive shock |
| Q67653235 | Regional neurotransmitter responses after acute and chronic electroconvulsive shock |
| Q60644675 | Repeated administration of subconvulsant doses of GABA antagonist drugs |
| Q71548675 | Repeated electroconvulsive shock prevents the sedative effect of small doses of apomorphine |
| Q34185892 | Repeated electroconvulsive shock produces long-lasting increases in messenger RNA expression of corticotropin-releasing hormone and tyrosine hydroxylase in rat brain. Therapeutic implications |
| Q66979407 | Resolving doubts about ECT |
| Q60619444 | Ritanserin, a 5-HT2 receptor antagonist, does not modify ECT-induced prolactin release |
| Q41372016 | Selective effects of ECT on hypothalamic-pituitary activity |
| Q70036887 | The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients |
| Q51865796 | The effect of some anti-epilepsy drugs on enhancement of the monoamine-mediated behavioural responses following the administration of electroconvulsive shocks to rats |
| Q73458379 | Transcranial magnetic stimulation induces alterations in brain monoamines |
Search more.